EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Effect of Aspirin vs Enoxaparin on 90-Day Mortality in Patients Undergoing Hip or Knee Arthroplasty

CRISTAL Study Group, Verinder S Sidhu, Thu-Lan Kelly, Nicole Pratt, Stephen E Graves, Rachelle Buchbinder, Sam Adie, Kara Cashman, Ilana N Ackerman, Durga Bastiras, Roger Brighton, Alexander W R Burns und 35 weitere

JAMA Network Open · 2023

DOI: 10.1001/jamanetworkopen.2023.17838 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA Network Open, 2023. Verfasst von CRISTAL Study Group und 46 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, South Western Sydney Clinical School, Faculty of Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Venous Thromboembolism, Arthroplasty, Replacement, Knee, Arthroplasty, Replacement, Hip. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Ischemic heart disease remains the leading cause of mortality following hip and knee arthroplasty. Due to its antiplatelet and cardioprotective properties, aspirin has been proposed as an agent that could reduce mortality when used as venous thromboembolism (VTE) prophylaxis following these procedures.

Objective

To compare aspirin with enoxaparin in reducing 90-day mortality for patients undergoing hip or knee arthroplasty procedures. Design, Setting, and Participants This study was a planned secondary analysis of the CRISTAL cluster randomized, crossover, registry-nested trial performed across 31 participating hospitals in Australia between April 20, 2019, and December 18, 2020. The aim of the CRISTAL trial was to determine whether aspirin was noninferior to enoxaparin in preventing symptomatic VTE following hip or knee arthroplasty. The primary study restricted the analysis to patients undergoing total hip or knee arthroplasty for a diagnosis of osteoarthritis only. This study includes all adult patients (aged ≥18 years) undergoing any hip or knee arthroplasty procedure at participating sites during the course of the trial. Data were analyzed from June 1 to September 6, 2021.

Interventions

Hospitals were randomized to administer all patients oral aspirin (100 mg daily) or subcutaneous enoxaparin (40 mg daily) for 35 days after hip arthroplasty and 14 days after knee arthroplasty procedures. Main Outcomes and Measures The primary outcome was mortality within 90 days. The between-group difference in mortality was estimated using cluster summary methods.

Results

A total of 23 458 patients from 31 hospitals were included, with 14 156 patients allocated to aspirin (median [IQR] age, 69 [62-77] years; 7984 [56.4%] female) and 9302 patients allocated to enoxaparin (median [IQR] age, 70 [62-77] years; 5277 [56.7%] female). The mortality rate within 90 days of surgery was 1.67% in the aspirin group and 1.53% in the enoxaparin group (estimated difference, 0.04%; 95% CI, −0.05%-0.42%). For the subgroup of 21 148 patients with a nonfracture diagnosis, the mortality rate was 0.49% in the aspirin group and 0.41% in the enoxaparin group (estimated difference, 0.05%; 95% CI, −0.67% to 0.76%). Conclusions and Relevance In this secondary analysis of a cluster randomized trial comparing aspirin with enoxaparin following hip or knee arthroplasty, there was no significant between-group difference in mortality within 90 days when either drug was used for VTE prophylaxis. Trial Registration http://anzctr.org.au Identifier: ACTRN12618001879257

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous ThromboembolismArthroplasty, Replacement, KneeArthroplasty, Replacement, HipAdultHumansFemaleAdolescentAgedMaleEnoxaparinAspirin

Substanzen

EnoxaparinAspirin

Autor:innen und Institutionen

  • School of Clinical Medicine, South Western Sydney Clinical School, Faculty of Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia.
  • Whitlam Orthopaedic Research Centre, Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia.
  • Clinical and Health Sciences, Quality Use of Medicines Pharmacy Research Centre, University of South Australia, Adelaide, South Australia, Australia.
  • Australian Orthopaedic Association National Joint Replacement Registry, Adelaide, South Australia, Australia.
  • School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • School of Clinical Medicine, UNSW Medicine & Health, St George & Sutherland Clinical Campuses, Faculty of Medicine and Health, UNSW Sydney, New South Wales, Australia.

Zitieren

APA

CRISTAL Study Group, Sidhu, V. S., Kelly, T. L., Pratt, N., Graves, S. E., Buchbinder, R., Adie, S., Cashman, K., Ackerman, I. N., Bastiras, D., Brighton, R., Burns, A. W. R., Chong, B. H., Clavisi, O., Cripps, M., Dekkers, M., de Steiger, R., Dixon, M., Ellis, A., …, & Harris, I. A. (2023). Effect of Aspirin vs Enoxaparin on 90-Day Mortality in Patients Undergoing Hip or Knee Arthroplasty. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2023.17838

Vancouver

CRISTAL Study Group, Sidhu VS, Kelly TL, Pratt N, Graves SE, Buchbinder R, et al. Effect of Aspirin vs Enoxaparin on 90-Day Mortality in Patients Undergoing Hip or Knee Arthroplasty. JAMA Network Open. 2023. doi:10.1001/jamanetworkopen.2023.17838

BibTeX
@article{CRISTALStudyGroup2023,
  author = {CRISTAL Study Group, CRISTAL Study Group and Sidhu, Verinder S and Kelly, Thu-Lan and Pratt, Nicole and Graves, Stephen E and Buchbinder, Rachelle and Adie, Sam and Cashman, Kara and Ackerman, Ilana N and Bastiras, Durga and Brighton, Roger and Burns, Alexander W R and Chong, Beng Hock and Clavisi, Ornella and Cripps, Maggie and Dekkers, Mark and de Steiger, Richard and Dixon, Michael and Ellis, Andrew and Griffith, Elizabeth C and Hale, David and Hansen, Amber and Harris, Anthony and Hau, Raphael and Horsley, Mark and James, Dugal and Khorshid, Omar and Kuo, Leonard and Lewis, Peter L and Lieu, David and Lorimer, Michelle and MacDessi, Samuel J and McCombe, Peter and McDougall, Catherine and Mulford, Jonathan and Naylor, Justine Maree and Page, Richard S and Radovanovic, John and Solomon, Michael and Sorial, Rami and Summersell, Peter and Tran, Phong and Walter, William L and Webb, Steve and Wilson, Chris and Wysocki, David and Harris, Ian A},
  title = {Effect of Aspirin vs Enoxaparin on 90-Day Mortality in Patients Undergoing Hip or Knee Arthroplasty},
  journal = {JAMA Network Open},
  year = {2023},
  doi = {10.1001/jamanetworkopen.2023.17838}
}
Kostenlos starten →